Impact of AREDS Oral Micronutrient Supplementation on Geographic Atrophy Progression: Insights From thePhase 3 OAKS and DERBY Trials

Related

• 

  Expert Panel: Pegcetacoplan Safety

  Andre J. Witkin, MD

  David A. Eichenbaum, MD, FASRS

  Samuel Anthony Minaker, MD, MSc

  Janani Singaravelu, MS, MD

  Sunir J. Garg, MD, FACS, FASRS

  Annual Meeting Talks

  2024

• 

  Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy: An Anchored Matching-Adjusted Indirect Comparison of the Phase 3 Trials

  Paul Hahn, MD, PhD, FASRS

  Annual Meeting Talks

  2023

• 

  Clinical Utility of the Fellow Eye in Patients With Bilateral GA Due to AMD: Long-Term Data from thePegcetacoplan Clinical Program

  Diana V Do, MD, FASRS

  Annual Meeting Talks

  2025